Applications for Food and Drug Administration Approval to Market New Drug: Revision of Postmarketing Reporting Requirements; Discontinuance
Title: American Society of Hematology ASH_Comments_to_FDA_Re_FDA-2011-N-0898_Revision_of_Post_Marketing_Reporting_Requirements
American Society of Hematology (ASH) - Comment
This is comment on Rule
Applications for Food and Drug Administration Approval to Market New Drug: Revision of Postmarketing Reporting Requirements; Discontinuance
View Comment
Attachments:
American Society of Hematology ASH_Comments_to_FDA_Re_FDA-2011-N-0898_Revision_of_Post_Marketing_Reporting_Requirements
Title:
American Society of Hematology ASH_Comments_to_FDA_Re_FDA-2011-N-0898_Revision_of_Post_Marketing_Reporting_Requirements
Related Comments
View AllPublic Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0003
Feb 17,2012 11:59 PM ET
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0004
Feb 17,2012 11:59 PM ET
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0005
Feb 17,2012 11:59 PM ET
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0007
Feb 17,2012 11:59 PM ET
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0009
Feb 17,2012 11:59 PM ET